Department of Neurology, The Mitchell Center for Alzheimer's Disease and Related Brain Disorders, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas.
Huntington's Disease Society of America Center of Excellence at UTHealth, Houston, Texas.
Cogn Behav Neurol. 2022 Jun 1;35(2):85-94. doi: 10.1097/WNN.0000000000000301.
Depression and suicidality are commonly experienced by Huntington disease (HD) gene carriers. Research on these behavioral symptoms is imperative, not only to increase our understanding of the symptoms and how they relate to HD, but also to contribute to improving patients' care and quality of life.
To identify clinical variables associated with a history of depression and suicidality in HD gene carriers.
We conducted a cross-sectional study of HD gene carriers from the Enroll-HD database PDS4 (periodic data set 4; N = 11,582). Data from baseline visits were obtained, and binary logistic regression models were used to ascertain the effects of clinical variables on the likelihood that HD gene carriers would have previous depression and suicidal ideation/attempts.
Approximately 65% (n = 7526) of the HD gene carriers had a history of depression, and ~27% (n = 3152) had previous suicidal ideation/attempts. Female sex; diagnosis of manifest HD; history of perseverative/obsessive behavior, apathy, and psychosis; and previous suicidal ideation/attempts were significantly associated with a history of depression in the HD gene carriers. Medical history of apathy, psychosis, and depression, as well as worse scores on the Total Functional Capacity and Irritability Scales, were significantly associated with previous suicidal ideation/attempts in the HD gene carriers.
The prevalence of depression and suicidality is high among HD gene carriers. An improved understanding of the risk factors for depression and suicide in HD gene carriers can assist providers in recognizing at-risk individuals and allow providers to implement therapeutic strategies.
亨廷顿病(HD)基因携带者常经历抑郁和自杀意念。对这些行为症状的研究至关重要,不仅可以增进我们对这些症状以及它们与 HD 之间关系的了解,还有助于改善患者的护理和生活质量。
确定与 HD 基因携带者抑郁和自杀意念史相关的临床变量。
我们对 Enroll-HD 数据库 PDS4(定期数据集 4;N=11582)中的 HD 基因携带者进行了横断面研究。从基线访视中获取数据,并使用二元逻辑回归模型确定临床变量对 HD 基因携带者既往抑郁和自杀意念/尝试可能性的影响。
约 65%(n=7526)的 HD 基因携带者有抑郁史,约 27%(n=3152)有既往自杀意念/尝试史。女性性别;显性 HD 诊断;有持续/强迫行为、冷漠和精神病病史;以及既往自杀意念/尝试与 HD 基因携带者的抑郁史显著相关。冷漠、精神病和抑郁的病史,以及总功能能力和易怒量表评分较差,与 HD 基因携带者的既往自杀意念/尝试显著相关。
HD 基因携带者中抑郁和自杀意念的患病率较高。更好地了解 HD 基因携带者中抑郁和自杀的风险因素可以帮助提供者识别高危个体,并使提供者能够实施治疗策略。